CN118215669A - 异野漆树苷及其衍生物用于促进神经修复的用途 - Google Patents

异野漆树苷及其衍生物用于促进神经修复的用途 Download PDF

Info

Publication number
CN118215669A
CN118215669A CN202280071472.9A CN202280071472A CN118215669A CN 118215669 A CN118215669 A CN 118215669A CN 202280071472 A CN202280071472 A CN 202280071472A CN 118215669 A CN118215669 A CN 118215669A
Authority
CN
China
Prior art keywords
nerve
isorhoifolin
brain
derivatives
injury
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280071472.9A
Other languages
English (en)
Chinese (zh)
Inventor
陈令仪
廖彣玲
王翊
李育棠
吕亭萱
李家维
陈裕仁
陈方仪
焦传金
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN118215669A publication Critical patent/CN118215669A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN202280071472.9A 2021-10-25 2022-10-25 异野漆树苷及其衍生物用于促进神经修复的用途 Pending CN118215669A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163271411P 2021-10-25 2021-10-25
US63/271,411 2021-10-25
PCT/CN2022/127372 WO2023072069A1 (zh) 2021-10-25 2022-10-25 异野漆树苷及其衍生物用于促进神经修复的用途

Publications (1)

Publication Number Publication Date
CN118215669A true CN118215669A (zh) 2024-06-18

Family

ID=86159046

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202280071472.9A Pending CN118215669A (zh) 2021-10-25 2022-10-25 异野漆树苷及其衍生物用于促进神经修复的用途
CN202280071353.3A Pending CN118139869A (zh) 2021-10-25 2022-10-25 异丙基-d-吡喃葡萄糖苷衍生物、制备方法及其用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202280071353.3A Pending CN118139869A (zh) 2021-10-25 2022-10-25 异丙基-d-吡喃葡萄糖苷衍生物、制备方法及其用途

Country Status (7)

Country Link
US (2) US20240415859A1 (cg-RX-API-DMAC7.html)
EP (2) EP4424695A4 (cg-RX-API-DMAC7.html)
JP (2) JP2024539499A (cg-RX-API-DMAC7.html)
KR (2) KR20240090982A (cg-RX-API-DMAC7.html)
CN (2) CN118215669A (cg-RX-API-DMAC7.html)
TW (1) TWI898161B (cg-RX-API-DMAC7.html)
WO (2) WO2023072085A1 (cg-RX-API-DMAC7.html)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101045072A (zh) * 2007-05-08 2007-10-03 胡军 山香圆叶提取物及其医药用途
CN102617659A (zh) * 2012-03-09 2012-08-01 中国烟草总公司郑州烟草研究院 α-紫罗兰醇葡糖苷的合成方法及其在卷烟中的加香应用
CN102617658B (zh) * 2012-03-09 2014-08-20 中国烟草总公司郑州烟草研究院 β-紫罗兰醇-β-D-葡糖苷的制备方法及其在烟草加香中的应用
CN106167508A (zh) * 2016-07-13 2016-11-30 上海应用技术学院 一种具有紫罗兰香味的葡萄糖苷化合物及其制备方法

Also Published As

Publication number Publication date
JP2024541121A (ja) 2024-11-06
US20240415859A1 (en) 2024-12-19
TW202320806A (zh) 2023-06-01
KR20240090983A (ko) 2024-06-21
KR20240090982A (ko) 2024-06-21
EP4424694A1 (en) 2024-09-04
TWI898161B (zh) 2025-09-21
WO2023072069A1 (zh) 2023-05-04
US20250255893A1 (en) 2025-08-14
CN118139869A (zh) 2024-06-04
TW202317142A (zh) 2023-05-01
EP4424695A4 (en) 2025-10-22
EP4424695A1 (en) 2024-09-04
WO2023072085A1 (zh) 2023-05-04
JP2024539499A (ja) 2024-10-28
EP4424694A4 (en) 2026-03-11

Similar Documents

Publication Publication Date Title
CN106795490B (zh) 用线粒体特化细胞治疗神经退行性疾病的医药组合物
Thanos et al. Traumatology of the optic nerve and contribution of crystallins to axonal regeneration
CN120699131B (zh) 治疗帕金森病的化学遗传学基因治疗新方案
Stepanova et al. Isolation of rat olfactory ensheathing cells and their use in the therapy of posttraumatic cysts of the spinal cord
Lepore Intraspinal cell transplantation for targeting cervical ventral horn in amyotrophic lateral sclerosis and traumatic spinal cord injury
Parvin et al. Effects of artemisinin and TSP‑1‑human endometrial‑derived stem cells on a streptozocin‑induced model of Alzheimer’s disease and diabetes in Wistar rats
TWI898161B (zh) 異野漆樹苷及其衍生物用於促進神經修復的用途
Anoop et al. A New Technique and Device for Controlled and Continuous Drug Delivery into the Brain–A Proof of Concept Study
Voronova et al. Survival and migration of rat olfactory ensheathing cells after transplantation into posttraumatic cysts in the spinal cord
CN117838730A (zh) 一种神经干细胞外囊泡在制备治疗脑出血继发性损伤的药物中的应用及药物组合物
RU2129427C1 (ru) Способ лечения заболеваний центральной нервной системы
RU2206299C2 (ru) Способ лечения заболеваний зрительного анализатора
JP2024539499A5 (cg-RX-API-DMAC7.html)
RU2375022C1 (ru) Способ лечения атрофии зрительного нерва различной этиологии
Cheng et al. Rag1−/− mice with T and B lymphocyte deficiency exhibit milder retinal inflammatory response and retinal ganglion cell injury after optic nerve crush
Shkap et al. Fate of Transplanted Allogeneic Mesenchymal Stromal Cells in the Rat Spinal Cord under Normal Conditions and during the Acute Phase of Spinal Cord Contusion Injury
TWI823110B (zh) 天南星科萃取物用於促進神經修復的用途
Hwang et al. Stem cells ameliorate neurotrauma-induced visual disturbances and retinopathy via broad normalization of the β-catenin-related signaling pathway
CN120617308A (zh) CD8α阳性巨噬细胞在视神经损伤治疗中的应用
WO2023202682A1 (zh) 治疗或诊断情绪障碍或应激障碍的新靶点和其应用
Hesse 11 Surgical Treatments
CN115944713A (zh) 一种神经营养因子和穿透肽组合物及其应用
JP2024541121A5 (cg-RX-API-DMAC7.html)
CN119454962A (zh) 神经颗粒素抑制剂在制备治疗神经损伤相关疾病的药物中的应用
MCCORD THE GLANDS OF INTERNAL SECRETION AND THEIR IMPORTANCE AS THERAPEUTIC

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination